We and others have previously shown that the ablation of host MMP-9 has a minimal impact on tumor/growth or tumor induced osteolysis [18], [45] thus implicating the importance of MMP-2 in the progression of bone metastases. The gene discussed is MMP9; the disease is neoplasm.